Saturday 21 December 2024
Internal Reference Number: FOI_7746
Date Request Received: 12/02/2024 00:00:00
Date Request Replied To: 05/03/2024 00:00:00
This response was sent via: By Email
Request Summary: Histopathology services and outsourcing
Request Category: Private Individuals
| Question Number 1: For the period April 1st to December 31st 2023, please provide the following information: How many whole time equivalent histopathology consultants (as defined by being on the GMC specialist register for pathology) were employed by the authority at 31/12/2023. | |
| Answer To Question 1: 4.8wte | |
| Question Number 2: How many histology cases were reported in the following period, overall and by the following sub-specialties - dermatology - gastro-intenstinal - urology - gynaecology - breast - thoracic - head and neck - other - total cases reported | |
| Answer To Question 2: dermatology - 3,469 gastro-intestinal - 3,833 urology - 683 gynaecology - 1,640 breast - 676 thoracic (including H&N) - 496 Other - 1,198 total cases reported - 11,995 | |
| Question Number 3: How many of the total cases given above were reported by a. consultants (or other medical staff) employed by the authority during their contract Programmed Activities or PAs. b. consultants employed by the authority, being paid additional amounts over and above their salary for additional work. c. locum consultants working for the authority d. external reporting companies. Please provide a total number of cases and the number reported by each of the following: - Unilabs - HCA Laboratories including their subsidiary Backlogs - Source LD Path (previously Source Bioscience, and LD Path limited) - Cellular Pathology Services Limited - Diagnexia - Digital Pathology Partners - Cyted (including their subsidiary Pathognomics) - Poundbury Cancer Institute - Medica - external reporting companies total | |
| Answer To Question 3: Of the total workload over the stated period I can provide the following data. 7% (888 cases) were reported by LD Path (They may be part of Source but we use them/pay for them as a separate company) 13% (1528) were reported by Poundbury 15% (1855) were reported by Source Bioscience Total of 4271 of the 11995 cases received between 1.4.23 – 31.12.23 were reported by outsourcing companies. | |
| Question Number 4: How much did the authority spend on each of the following during the period a. consultants (or other medical staff) employed by the authority during their contract Programmed Activities or PAs. (salary plus NI plus pension contrbution) b. consultants employed by the authority, being paid additional amounts over and above their salary for additional work. c. locum consultants working for the authority d. external reporting companies. Please provide a total spend and the spend with each of the following: - Unilabs - HCA Laboratories including their subsidiary Backlogs - Source LD Path (previously Source Bioscience, and LD Path limited) - Cellular Pathology Services Limited - Diagnexia - Digital Pathology Partners - Cyted (including their subsidiary Pathognomics) - Poundbury Cancer Institute - Medica - external reporting companies total | |
| Answer To Question 4: .See attached file FOI 7746 To accompany this answer to question 4 please also see the documents listed below:  FOI 7746.xlsx | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
